Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:age |
patients 9 years and older
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
D11AA10
|
| gptkbp:brand |
gptkb:Qbrexza
|
| gptkbp:chemicalClass |
quaternary ammonium compound
|
| gptkbp:form |
pre-moistened cloth
|
| gptkbp:genericName |
glycopyrronium tosylate
|
| https://www.w3.org/2000/01/rdf-schema#label |
Qbrexza
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Dermira
|
| gptkbp:mechanismOfAction |
anticholinergic
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:sideEffect |
constipation
blurred vision mydriasis dry mouth urinary retention |
| gptkbp:usedFor |
primary axillary hyperhidrosis
|
| gptkbp:bfsParent |
gptkb:Dermira
gptkb:Journey_Medical_Corporation |
| gptkbp:bfsLayer |
8
|